CORC

在结果中检索

CORC

浏览/检索结果: 共60条，第1-10条 帮助

已选(0)清除 条数/页：   排序方式：
A Case of Resistance to Selective RET-TKI Therapy With Pleural-Genotyped MET Amplification and Response to Crizotinib 期刊论文
CLINICAL LUNG CANCER, 2021, 卷号: 22
作者:  Chen, Kaiyan;  Zhang, Fanrong;  Pan, Guoqiang;  Sheng, Jiamin;  Ye, Junyi
收藏  |  浏览/下载：26/0  |  提交时间：2021/03/15
Phase III Randomized Study of Ensartinib vs Crizotinib in Anaplastic Lymphoma Kinase (ALK) POSITIVE NSCLC Patients: eXalt3 期刊论文
JOURNAL OF THORACIC ONCOLOGY, 2020, 卷号: 15
作者:  Selvaggi, G.;  Wakelee, H. A.;  Mok, T.;  Wu, Y. -L.;  Reck, M.
收藏  |  浏览/下载：28/0  |  提交时间：2020/11/30
SAF-189s, a potent new-generation ROS1 inhibitor, is active against crizotinib-resistant ROS1 mutant-driven tumors 期刊论文
ACTA PHARMACOLOGICA SINICA, 2020, 页码: 7
作者:  Xia, Zong-jun;  Ji, Yin-chun;  Sun, De-qiao;  Peng, Xia;  Gao, Ying-lei
收藏  |  浏览/下载：75/0  |  提交时间：2020/12/21
ALK-G1269A mutation in epithelioid inflammatory myofibroblastic sarcoma after progression on crizotinib: A case report 期刊论文
ONCOLOGY LETTERS, 2019, 卷号: 17, 期号: 2
作者:  Xu, Xiaojing;  Li, Hong;  Peng, Ke;  Yu, Yiyi;  Chen, Lingli
收藏  |  浏览/下载：22/0  |  提交时间：2019/12/05
Different Types of ROS1 Fusion Partners Yield Comparable Efficacy to Crizotinib 期刊论文
ONCOLOGY RESEARCH, 2019, 卷号: 27, 期号: 8
作者:  He, Yueming;  Sheng, Wang;  Hu, Weiguo;  Lin, Jing;  Liu, Junjun
收藏  |  浏览/下载：49/0  |  提交时间：2019/12/05
A case report of metastatic bilateral ovarian cancer due to non-small cell lung cancer with ALK gene rearrangement 期刊论文
EUROPEAN JOURNAL OF GYNAECOLOGICAL ONCOLOGY, 2019, 卷号: 40, 期号: 1, 页码: 151-153
作者:  Liu, Zhitong;  Liu, Bo;  Li, Changzhong
收藏  |  浏览/下载：5/0  |  提交时间：2019/12/11
Elevated levels of pre-treatment lactate dehydrogenase are an unfavorable predictor factor in patients with EML4-ALK rearrangement non-small cell lung cancer treated with crizotinib 期刊论文
2019, 卷号: 11, 页码: 8191-8200
作者:  Liang Hongge;  Ma Di;  Xu Yan;  Zhao Jing;  Chen Minjiang
收藏  |  浏览/下载：28/0  |  提交时间：2020/01/03
Treatment duration as a surrogate endpoint to evaluate the efficacy of crizotinib in sequential therapy for patients with advanced ALK-positive non-small cell lung cancer: A retrospective, real-world study 期刊论文
2019, 卷号: 8, 期号: 13, 页码: 5823-5830
作者:  Yang Guangjian;  Ma Di;  Xu Haiyan;  Yang Lu;  Li Junling
收藏  |  浏览/下载：3/0  |  提交时间：2020/01/03
Impact of crizotinib on long-term survival of ALK-positive advanced non-small-cell lung cancer: A Chinese multicenter cohort study 期刊论文
2019, 卷号: 31, 期号: 3, 页码: 481-+
作者:  Xing, Puyuan;  Ma, Di;  Wang, Qiang;  Hao, Xuezhi;  Wang, Mengzhao
收藏  |  浏览/下载：15/0  |  提交时间：2020/01/03
Sequential therapy according to distinct disease progression patterns in advanced ALK-positive non-small-cell lung cancer after crizotinib treatment 期刊论文
2019, 卷号: 31, 期号: 2, 页码: 349-356
作者:  Xu, Haiyan;  Ma, Di;  Yang, Guangjian;  Li, Junling;  Hao, Xuezhi
收藏  |  浏览/下载：10/0  |  提交时间：2020/01/03

©版权所有 ©2017 CSpace - Powered by CSpace